Processa Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINEPRE 14AProcessa Pharmaceuticals, Inc.PCSAOct 9

   Processa Pharmaceuticals merges with Vidya

   • Completed merger with Vidya Therapeutics on July 28, 2026
   • Issued 142,254.972 shares of Series A Preferred Stock to Vidya shareholders
   • Raised $200 million via PIPE Preferred Shares on July 30, 2026
2. ROUTINEPRE 14AProcessa Pharmaceuticals, Inc.PCSAOct 9

   Processa Pharmaceuticals announces merger

   • Completed merger with Vidya Therapeutics, Inc. on July 28, 2026
   • Issued 142,254.972 shares of Series A Preferred Stock to Vidya shareholders
   • Raised $200 million through 2026 Private Placement
3. ROUTINES-3Processa Pharmaceuticals, Inc.PCSAOct 9

   Processa Pharmaceuticals files S-3 registration

   • Filed S-3 on 2026-10-09
   • Registers 306,574,202 shares of common stock
   • Selling stockholders may resell shares from merger and private placement
4. ROUTINE8-K/AProcessa Pharmaceuticals, Inc.PCSAOct 5

   Processa Pharmaceuticals acquires Vidya Therapeutics

   • Acquired Vidya Therapeutics on July 28, 2026
   • Received $200M in financing from investors
   • VT7208 is now lead product candidate
5. ROUTINESCHEDULE 13GProcessa Pharmaceuticals, Inc.PCSAAug 18

   Ownership stake disclosure by Soleus Capital Master Fund, L.P.

   Soleus Capital Master Fund, L.P., filed by

6. NOTABLE10-QProcessa Pharmaceuticals, Inc.PCSAAug 14

   Quarterly report

7. ROUTINE4Processa Pharmaceuticals, Inc.PCSAAug 11

   George K Ng, insider filing for PCSA

   George K Ng, reporting

8. ROUTINE8-KProcessa Pharmaceuticals, Inc.PCSAAug 4

   Current report

9. ROUTINE4Processa Pharmaceuticals, Inc.PCSAJul 30

   2 insider filings

   Sheila Gujrathi, insider filing for PCSA

   Show all 2

   • 4Insider filing for PCSAJul 30
   • 3New insider at PCSAJul 30

   Sheila Gujrathi, reporting

10. ROUTINE8-KProcessa Pharmaceuticals, Inc.PCSAJul 29

    Current report

11. ROUTINE4Processa Pharmaceuticals, Inc.PCSAJul 28

    8 insider filings

    Justin W Yorke, insider filing for PCSA

    Show all 8

    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28
    • 4Insider filing for PCSAJul 28

    Justin W Yorke, reporting

12. ROUTINE4Processa Pharmaceuticals, Inc.PCSAJul 1

    5 insider filings

    Wendy Guy, insider filing for PCSA

    Show all 5

    • 4Insider filing for PCSAJul 1
    • 4Insider filing for PCSAJul 1
    • 4Insider filing for PCSAJul 1
    • 4Insider filing for PCSAJul 1
    • 4Insider filing for PCSAJul 1

    Wendy Guy, reporting

13. ROUTINE4Processa Pharmaceuticals, Inc.PCSAJun 30

    4 insider filings

    Justin W Yorke, insider filing for PCSA

    Show all 4

    • 4Insider filing for PCSAJun 30
    • 4Insider filing for PCSAJun 30
    • 4Insider filing for PCSAJun 30
    • 4Insider filing for PCSAJun 30

    Justin W Yorke, reporting

14. ROUTINEDEF 14AProcessa Pharmaceuticals, Inc.PCSAJun 18

    Proxy statement

15. ROUTINE4Processa Pharmaceuticals, Inc.PCSAJun 16

    5 insider filings

    David Young, insider filing for PCSA

    Show all 5

    • 4Insider filing for PCSAJun 16
    • 4Insider filing for PCSAJun 16
    • 4Insider filing for PCSAJun 16
    • 4Insider filing for PCSAJun 16
    • 4Insider filing for PCSAJun 16

    David Young, reporting

16. ROUTINE4Processa Pharmaceuticals, Inc.PCSAJun 1

    5 insider filings

    David Young, insider filing for PCSA

    Show all 5

    • 4Insider filing for PCSAJun 1
    • 4Insider filing for PCSAJun 1
    • 4Insider filing for PCSAJun 1
    • 4Insider filing for PCSAJun 1
    • 4Insider filing for PCSAJun 1

    David Young, reporting

17. ROUTINE4Processa Pharmaceuticals, Inc.PCSAMay 19

    7 insider filings

    George K Ng, insider filing for PCSA

    Show all 7

    • 4Insider filing for PCSAMay 19
    • 4Insider filing for PCSAMay 19
    • 4Insider filing for PCSAMay 19
    • 4Insider filing for PCSAMay 19
    • 4Insider filing for PCSAMay 19
    • 4/AInsider filing for PCSA (amended)May 19
    • 4/AInsider filing for PCSA (amended)May 19

    George K Ng, reporting

18. ROUTINESCHEDULE 13G/AProcessa Pharmaceuticals, Inc.PCSAMay 15

    Ownership stake disclosure by CVI Investments, Inc. (amended)

    CVI Investments, Inc., filed by

19. NOTABLE10-QProcessa Pharmaceuticals, Inc.PCSAMay 7

    Quarterly report

20. ROUTINE4Processa Pharmaceuticals, Inc.PCSAMay 1

    2 insider filings

    David Young, insider filing for PCSA

    Show all 2

    • 4Insider filing for PCSAMay 1
    • 4Insider filing for PCSAMay 1

    David Young, reporting

Older filings on EDGAR